← Leaderboards
Marc Philippon
Steadman Philippon Research Institute
$1,028,447
Attributed
$3,085,341
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $790.3K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,085,341 · 2
By mechanism
UH3$2,563,053 · 1
UG3$522,288 · 1
Top collaborators
- Johnny Huard6 shared
- Scott Tashman6 shared
Others in their field
Other Emerging Leaders on “Cell Aging”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Hemali Phatnani · New York University School Of Medicine$19,091,830
- Leslie M Schoop · The University Corporation, Northridge$17,700,000
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
Research focus
Cell AgingCellsAdultAftercareAdipose TissueCell DeathApoptosisAdult Stem Cell TransplantationArthropathiesArticular CartilageAllograftingAutologousAdult Stem CellBiological MarkersBiological Response Modifier TherapyBloodBone MarrowApoptoticBone Marrow Stem CellCartilageCartilage DegradationCartilage DiseasesCartilage RepairCell Type
Grant awards (6)
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis$551,586
UH3 · FY2024 · AR
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis$600,051
UH3 · FY2023 · AR
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis$621,091
UH3 · FY2022 · AR
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis$633,825
UH3 · FY2021 · AR
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis$156,500
UH3 · FY2021 · AR
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis$522,288
UG3 · FY2020 · AR